Company / Free Cash Flow per Share
INOVIO PHARMACEUTICALS, INC. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.90
FY2025
5-year range
-$10.29 / -$0.53
FY2021-FY2025
Trend
+47.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-10.29 in FY2023 to $-0.21 in FY2017.
Based on SEC 10-K filings.
-2.90 in FY2025.
Improved from $-10.29 to $-2.90 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share increased 47.1% year-over-year.
- Peak free cash flow per share was recorded in FY2017.
- Lowest free cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.90 | +47.1% |
| FY2024 | -$5.47 | +46.8% |
| FY2023 | -$10.29 | -1145.7% |
| FY2022 | -$0.83 | -56.1% |
| FY2021 | -$0.53 | +29.1% |
| FY2020 | -$0.75 | +1.3% |
| FY2019 | -$0.76 | -4.6% |
| FY2018 | -$0.72 | -251.6% |
| FY2017 | -$0.21 | +52.4% |
| FY2016 | -$0.43 | -68.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026